Soleno Therapeutics (SLNO) surges 33%+ premarket on Neurocrine’s $2.9B all-cash bid — April 6, 2026
Soleno Therapeutics (NASDAQ: SLNO) surged more than 33% in premarket trading on...
September 10, 2026
Browse Tag
VYKAT XR Prader-Willi syndrome
2 Articles
Opening bell, April 6, 2026: SLNO surges 33%+ on $2.9B Neurocrine bid as S&P 500 opens at 6,587
U.S. equities opened modestly higher on Monday, April 6, 2026, with the S&P...
Trending News
Stay Connected
Get Every Newsletter
Get notified of the best deals on our WordPress themes.